Home > Insider Trading > Glaxosmithkline Plc

Glaxosmithkline Plc (GSK)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
151 - 160
Next >>

Medecins Sans Frontieres Happy with GlaxoSmithKline PLC (ADR) (GSK) Price Reduction For Synflorix

Numerous complaints by medical charity Medecins Sans Frontieres over the cost of pneumococcal vaccine given to refugees by GlaxoSmithKline PLC (ADR) (NYSE:GSK) have yielded fruit.

Keep Reading →

September 20th, 2016 - News Stock Analysis

Inside the FDA Ebola Edition: Frontrunners Merck & Co., Inc. (MRK), GlaxoSmithKline PLC (ADR) (GSK)

Back on May 12, 2015, the Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee released a briefing document detailing the process for licensure of Ebola vaccines...

Keep Reading →

August 29th, 2016 - News Stock Analysis

Why Are These Five Stocks on Investors' Radars Today?

Markets are struggling to find a direction on Monday amid the Institute for Supply Management data that showed that its index of national factory activity amounted to 52.6 in June, missing the consensus...

Keep Reading →

August 1st, 2016 - Earnings Report News Tech

Why Fiat Chrysler, Coca-Cola, Anthem and 2 Other Stocks Are Moving Today

While Apple Inc.

Keep Reading →

July 27th, 2016 - Earnings Report Market Movers News

Why GlaxoSmithKline, Groupon, Lending Club And 2 Micro-Caps Are Trending Today

The U.S stock markets are trading up on Monday even as oil has tumbled, thanks to strong financial results and M&A news. Among the stocks on the move today are LendingClub Corp (NYSE:LC), Ballard Power...

Keep Reading →

July 18th, 2016 - Market Movers News

With Brexit Looming, Hedge Funds Weigh In On British Stocks

The Brexit is looming and, no matter how cute a name we can come up with, the issue is as serious as can be.

Keep Reading →

June 13th, 2016 - Hedge Fund Analysis Hedge Funds

GlaxoSmithKline PLC (ADR) (GSK) To Accelerate Filing For COPD Combo Treatment

GlaxoSmithKline plc (ADR) (NYSE:GSK) has come up with a plan that will enable it to file for approval of its triple-combo drug for COPD patients sooner than earlier anticipated.

Keep Reading →

June 9th, 2016 - News Stock Analysis

Johnson & Johnson (JNJ) And GlaxoSmithKline PLC (ADR) (GSK) Rheumatoid Arthritis Drug Meets Targets In Large Phase 3 Study

A drug being developed jointly by Johnson & Johnson (NYSE:JNJ) and GlaxoSmithKline plc (ADR) (NYSE:GSK) met endpoints in a large Phase 3 study that enrolled 1,670 patients.

Keep Reading →

June 8th, 2016 - News Stock Analysis

GlaxoSmithKline PLC (ADR) (GSK) Poised To Overtake Sanofi SA (ADR) (SNY) In This $1.8 Billion Market

GlaxoSmithKline PLC (ADR) (NYSE:GSK) is on the verge of leapfrogging Sanofi SA (ADR) (NYSE:SNY) in the meningococcal vaccine market in terms of sales.

Keep Reading →

June 8th, 2016 - News Stock Analysis